Rosuvastatin (RST) is a poorly water-soluble drug responsible
for
limited in vivo dissolution and subsequently low oral systemic absorption
(poor bioavailability). The mole fraction solubility values of RST
in various ratios of binary mixtures “{PEG400 (1) + water (2)}”
at 298.15 K were employed to investigate the preferential solvation
(PS) of RST (3) by the binary components. Moreover, the GastroPlus
program predicted the drug dissolution/absorption rates, plasma drug
concentration, and compartmental regional drug absorbed from a conventional
tablet as compared to the RST-loaded (PEG400 + water) mixture (at x
1 = 0.5) in healthy subjects (considering the
fast condition). Fedors’ method was adopted to estimate the
values of molar volume (314.8 cm3·mol–1) and Hildebrand solubility parameter (28.08 MPa1/2) of
RST. The results of inverse Kirkwood–Buff integrals showed
the PS of RST by PEG400 as observed in all studied ratios of the binary
mixture. The highest PS value (δx
1,3 = 1.65 × 10–2) for RST by PEG400 was attained
at x
1 = 0.5. Finally, the GastroPlus program
predicted the maximum dissolution rate [20 mg within 15 min as compared
to pure RST (1.5 mg within 15 min)]. Moreover, the program predicted
increased in vivo oral absorption (1.2 μg/mL) and enhanced regional
absorption (95.3%) of RST from upper segments of the gastrointestinal
tract for the RST-loaded PEG400 + water mixture in humans as compared
to conventional tablets (87.5% as total regional absorption and 0.88
μg/mL as in vivo absorption). Hence, the present binary system
ferrying RST can be a promising strategy to control systemic dyslipidemia
after oral or subcutaneous administration.